CompletedNCT02287038
Atomoxetine for Veterans With ADHD and PTSD
About this title
Read the official source — NCT02287038Medication studyAges 20–60United States
Understand this study
Who was this study for?
Listed age limits: 20 years to 60 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 15, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 44
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 20 Years to 60 Years
- Official registry ID
- NCT02287038
- Official title
Show the full official title
Atomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine 80 MG.
Who was this study for?
Listed age limits: 20 years to 60 years.
